in Newswire April 3, 2020

Avet's Metformin Diabetes Drug Found to Contain Probable Carcinogen, Class Action Claims

by Erin Shaak

Last Updated on April 3, 2020

Hann v. Heritage Pharmaceuticals, Inc.

Filed: March 30, 2020 § 3:20-cv-03415-BRM-LHG

According to a class action, generic metformin manufactured by Heritage Pharmaceuticals has been found to contain dangerously high levels of a probable carcinogen.

Law(s)

State(s)

New Jersey

Last Updated on April 3, 2020 — 12:04 PM

Erin Shaak

erin@classaction.org

Erin works primarily on ClassAction.org’s newswire, reporting on cases as they happen.

About ClassAction.org

ClassAction.org is a group of online professionals (designers, developers and writers) with years of experience in the legal industry.

Learn More

Before commenting, please review our comment policy.